Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Emily A Duffield
Safety of Checkpoint Inhibitors for Cancer Treatment: Strategies for Patient Monitoring and Management of Immune-Mediated Adverse Events
ImmunoTargets and Therapy
Allergy
Immunology
Related publications
Treatment- And Immune-Related Adverse Events of Immune Checkpoint Inhibitors in Advanced Lung Cancer
Bioscience Reports
Biochemistry
Cell Biology
Molecular Biology
Biophysics
5) Management of Neurological Adverse Events Associated With Immune Checkpoint Inhibitors
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
Review: Immune-Related Adverse Events With Use of Checkpoint Inhibitors for Immunotherapy of Cancer
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
Management of Immune Checkpoint Inhibitor‐related Dermatologic Adverse Events
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
EULAR Points to Consider for the Diagnosis and Management of Rheumatic Immune-Related Adverse Events Due to Cancer Immunotherapy With Checkpoint Inhibitors
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Review of Cancer Treatment With Immune Checkpoint Inhibitors
Wiener Klinische Wochenschrift
Medicine
4) Immune-Related Adverse Events in Endocrine Organs Induced by Immune Checkpoint Inhibitors
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
Immune Checkpoint Inhibitors for Metastatic Bladder Cancer
Cancer Treatment Reviews
Medicine
Oncology
Radiology
Nuclear Medicine
Imaging
Treatment-Related Adverse Events and Response Rate to Immune Checkpoint Inhibition
Journal of International Medical Research
Biochemistry
Medicine
Cell Biology